TTT

Rhelion Life Sciences Corp.

No trades
No trades

Compare with Rhelion Life Sciences Corp.


Market capitalization
‪10.74 M‬ USDNano cap
−0.0104 USD
‪−4.39 M‬ USD
‪3.02 M‬ USD
‪575.17 M‬
Beta (1Y)
1.40
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Company info


CEO
Todd Michael Shapiro
Headquarters
Toronto
Founded
1982
ISIN
CA76206T1084
CUSIP
76206T108
FIGI
BBG00FQ9LS67
Identifiers
ISIN CA76206T1084
CFI code
ESXXXR
Rhelion Life Sciences Corp. engages in the production and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a psilocybin truffle to the legal, recreational market within the Netherlands. It operates through the following geographical segments: Netherlands, Canada, and United States. The company was founded by Todd Michael Shapiro on September 29, 1982 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of TRUFF is 0.0194 USD — it has decreased by −2.71% in the past 24 hours. Watch Rhelion Life Sciences Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Rhelion Life Sciences Corp. stocks are traded under the ticker TRUFF.
TRUFF stock has fallen by −3.20% compared to the previous week, the month change is a −4.16% fall, over the last year Rhelion Life Sciences Corp. has showed a −15.64% decrease.
TRUFF reached its all-time high on Feb 10, 2021 with the price of 0.5600 USD, and its all-time low was 0.0050 USD and was reached on Mar 11, 2026. View more price dynamics on TRUFF chart.
See other stocks reaching their highest and lowest prices.
TRUFF stock is 4.74% volatile and has beta coefficient of 1.40. Track Rhelion Life Sciences Corp. stock price on the chart and check out the list of the most volatile stocks — is Rhelion Life Sciences Corp. there?
Today Rhelion Life Sciences Corp. has the market capitalization of ‪10.74 M‬, it has decreased by −16.52% over the last week.
Yes, you can track Rhelion Life Sciences Corp. financials in yearly and quarterly reports right on TradingView.
Rhelion Life Sciences Corp. is going to release the next earnings report on Dec 2, 2026. Keep track of upcoming events with our Earnings Calendar.
TRUFF net income for the last quarter is ‪−1.05 M‬ USD, while the quarter before that showed ‪−1.82 M‬ USD of net income which accounts for 0.00% change. Track more Rhelion Life Sciences Corp. financial stats to get the full picture.
No, TRUFF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Rhelion Life Sciences Corp. EBITDA is ‪−3.08 M‬ USD, and current EBITDA margin is −97.02%. See more stats in Rhelion Life Sciences Corp. financial statements.
Like other stocks, TRUFF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rhelion Life Sciences Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rhelion Life Sciences Corp. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rhelion Life Sciences Corp. stock shows the sell signal. See more of Rhelion Life Sciences Corp. technicals for a more comprehensive analysis.